Crossref
74. FIRE: Lightening the Mind: Low-Dose Naltrexone to Treat Autoimmune-Related Mood Disorders
Journal of the Academy of Consultation-Liaison Psychiatry · 2026-11 · 67 · S106
DOI: 10.1016/j.jaclp.2026.10.173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Academy of Consultation-Liaison Psychiatry, 2026-11. Verfasst von Lay Kodama und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kodama, L., Rand, M., & Muhammad, L. (2026). 74. FIRE: Lightening the Mind: Low-Dose Naltrexone to Treat Autoimmune-Related Mood Disorders. Journal of the Academy of Consultation-Liaison Psychiatry, 67, S106. https://doi.org/10.1016/j.jaclp.2026.10.173
Vancouver
Kodama L, Rand M, Muhammad L. 74. FIRE: Lightening the Mind: Low-Dose Naltrexone to Treat Autoimmune-Related Mood Disorders. Journal of the Academy of Consultation-Liaison Psychiatry. 2026;67:S106. doi:10.1016/j.jaclp.2026.10.173
BibTeX
@article{Kodama2026,
author = {Kodama, Lay and Rand, Michaela and Muhammad, Lama},
title = {74. FIRE: Lightening the Mind: Low-Dose Naltrexone to Treat Autoimmune-Related Mood Disorders},
journal = {Journal of the Academy of Consultation-Liaison Psychiatry},
year = {2026},
volume = {67},
pages = {S106},
doi = {10.1016/j.jaclp.2026.10.173}
}
EUVIMED